Femasys (FEMY) Financials: Revenue & Earnings

FEMY price $1.39 +0.02 +1.46%

Ticker
FEMY
Price
$1.39
Change
+0.02 +1.46%
Market cap ?
$11.64M
P/E ?
-0.33
Forward P/E ?
0.61
Dividend yield ?
0.00%
Beta ?
-2.15
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Stocklytics score
61
Value
59
Quality
35
Growth
88

Stocklytics score rationale: value 59, quality 35, growth 88.

Financials

2019202020212022202320242025
929064103791811796891206218107197016291082293313

Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering. For diagnostic purposes, Femasys provides FemCerv, a biopsy device utilized for…

Fair value

FEMY fair value $88.74. Price $1.39. Price is 98% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare FEMY

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-17—-0.47—763.00K
2026-08-14-1.33-1.31331.83K730.67K
2026-05-080.10-1.33424.89K767.00K
2026-03-26-1.25-1.67814.31K1.06M
2025-11-11-2.00-2.30729.39K1.35M
2025-08-08-3.20-3.27409.27K1.02M
2025-05-08-4.60-3.40341.26K1.14M
2025-03-27-4.60-3.70582.11K1.66M
2024-11-12-4.80-4.00554.91K677.17K
2024-08-08-4.20-3.25221.48K783.25K
2024-05-09-3.40-0.22271.14K776.50K
2024-03-28-3.80-0.21221.97K236.75K
2023-11-14-5.20-0.25244.36K281.00K
2023-08-09-0.22-0.19320.51K349.25K
2023-05-11-0.25-0.26293.98K340.00K
2023-03-30-4.80-5.20235.22K370.50K
2022-11-10-0.25-0.23347.46K351.50K
2022-08-10-4.40-0.25303.11K308.33K
2022-05-11-4.80-4.20321.40K300.00K
2022-03-24-1.60-0.23300.00K250.00K
2021-11-10-3.80-0.15269.58K300.00K
2021-08-11-1.84-0.15326.01K300.00K
2021-06-21-3.60-5.00280.96K300.00K
2020-09-30-0.17—313.21K—
2020-06-30-0.16—183.23K—
2020-03-31-0.24—260.51K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-07Mifek Jeffrey GeraldBuy3.12K$3.2010.00K
2026-08-07Mifek Jeffrey GeraldBuy3.12K$2.959.22K
2026-08-07Mifek Jeffrey GeraldBuy3.12K$2.959.22K
2026-08-07Sipos Jeremy AlexanderBuy3.12K$3.2010.00K
2026-08-07Sipos Jeremy AlexanderBuy3.12K$2.959.22K
2026-08-07Sipos Jeremy AlexanderBuy3.12K$2.959.22K
2026-08-07Canning John CharlesBuy4.38K$3.2014.00K
2026-08-07Canning John CharlesBuy4.38K$2.9512.91K
2026-08-07Canning John CharlesBuy4.38K$2.9512.91K
2026-08-07Elefant DovBuy15.62K$2.9546.09K
2026-08-07Elefant DovBuy15.62K$3.2050.00K
2026-08-07Elefant DovBuy15.62K$2.9546.09K
2026-08-07Lee-Sepsick KathyBuy15.62K$3.2050.00K
2026-08-07Lee-Sepsick KathyBuy15.62K$2.9546.09K
2026-08-07Lee-Sepsick KathyBuy15.62K$2.9546.09K
2026-07-06Mifek Jeffrey GeraldBuy6.25K$4.0825.50K
2026-07-06Mifek Jeffrey GeraldOther0——
2026-06-24Eichenbaum Kenneth D.Buy880$3.673.23K
2026-06-24Uzialko Edward RBuy880$3.673.23K
2026-06-24Milnes AlistairBuy880$3.673.23K
2026-06-24Larsen CharlesBuy880$3.673.23K
2026-03-30Canning John CharlesBuy150.00K$0.3857.00K
2026-03-30Canning John CharlesOther0——
2026-03-19Lee-Sepsick KathyBuy68.24K$0.5839.58K
2026-03-19Elefant DovBuy34.12K$0.5819.79K
2026-03-19Eichenbaum Kenneth D.Buy102.37K$0.5859.37K
2026-03-19Larsen CharlesBuy34.12K$0.5819.79K
2026-03-18Eichenbaum Kenneth D.Other0——
2026-03-18Eichenbaum Kenneth D.Buy35.20K$0.6021.12K
2026-03-17PharmaCyte Biotech, Inc.Other0——
2026-03-17Silverman JoshuaOther0——
2026-02-19Lee-Sepsick KathyBuy447.00K——
2026-02-19Lee-Sepsick KathyBuy282.00K——
2026-02-19Elefant DovBuy173.00K——
2026-02-19Elefant DovBuy169.00K——
2026-02-02Sipos Jeremy AlexanderBuy80.00K——
2025-12-16Sipos Jeremy AlexanderOther0——
2025-12-16Sipos Jeremy AlexanderOther27.78K$3.2490.00K
2025-12-16Sipos Jeremy AlexanderOther3.33K$6.1220.40K
2025-12-16Sipos Jeremy AlexanderOther14.80K$3.0044.40K
2025-12-16Sipos Jeremy AlexanderOther14.80K$0.8712.88K
2025-12-16Sipos Jeremy AlexanderOther34.70K$0.8027.76K
2025-12-16Sipos Jeremy AlexanderOther34.70K$1.0536.44K
2025-11-07Eichenbaum Kenneth D.Other102.37K$0.7374.73K
2025-11-07Eichenbaum Kenneth D.Other102.37K$0.8182.92K
2025-11-07Eichenbaum Kenneth D.Other102.37K$0.9294.18K
2025-11-07Eichenbaum Kenneth D.Other102.37K$1.10112.60K
2025-11-07Lee-Sepsick KathyBuy68.24K$1.1075.07K
2025-11-07Lee-Sepsick KathyBuy68.24K$0.8155.28K
2025-11-07Lee-Sepsick KathyBuy68.24K$0.9262.78K
2025-11-07Lee-Sepsick KathyBuy0$0.730
2025-11-07Larsen CharlesBuy34.12K$0.9231.39K
2025-11-07Larsen CharlesBuy34.12K$0.8127.64K
2025-11-07Larsen CharlesBuy34.12K$1.1037.53K
2025-11-07Larsen CharlesBuy0$0.730
2025-11-07Elefant DovBuy34.12K$1.1037.53K
2025-11-07Elefant DovBuy34.12K$0.8127.64K
2025-11-07Elefant DovBuy34.12K$0.9231.39K
2025-11-07Elefant DovBuy0$0.730
2025-08-27Elefant DovBuy38.83K$0.5220.00K
2025-08-27Elefant DovBuy38.83K$0.5220.00K
2025-08-27Lee-Sepsick KathyBuy48.53K$0.5225.00K
2025-08-27Lee-Sepsick KathyBuy48.53K$0.5225.00K
2025-06-25Uzialko Edward RBuy17.60K$0.9817.25K
2025-06-25Milnes AlistairBuy17.60K$0.9817.25K
2025-06-25Larsen CharlesBuy17.60K$0.9817.25K
2025-06-25Silverman JoshuaBuy17.60K$0.9817.25K
2025-06-23Nicholas Kelley StinsonBuy100.00K$0.9090.00K
2025-06-23Nicholas Kelley StinsonOther0——
2025-06-23Nicholas Kelley StinsonOther0——
2025-06-02Larsen CharlesBuy24.51K$1.0225.00K
2025-06-02Currie Daniel ScottBuy19.61K$1.0220.00K
2025-06-02Elefant DovBuy19.61K$1.0220.00K
2025-06-02Lee-Sepsick KathyBuy34.31K$1.0235.00K
2025-01-29Lee-Sepsick KathyBuy262.70K$1.17307.36K
2025-01-29Lee-Sepsick KathyBuy120.35K$1.17140.81K
2025-01-29Lee-Sepsick KathyBuy59.85K$1.1770.02K
2025-01-28Currie Daniel ScottBuy140.70K$1.05147.74K
2025-01-28Currie Daniel ScottBuy59.31K$1.0562.28K
2025-01-28Currie Daniel ScottBuy29.18K$1.0530.64K
2025-01-28Thomas Christine EBuy55.09K$1.0557.84K
2025-01-28Thomas Christine EBuy28.68K$1.0530.12K
2025-01-28Thomas Christine EBuy23.60K$1.0524.78K
2025-01-28Elefant DovBuy114.30K$1.05120.02K
2025-01-28Elefant DovBuy72.05K$1.0575.65K
2024-07-12Silverman JoshuaBuy17.60K$1.1420.06K
2024-07-12Larsen CharlesBuy17.60K$1.1420.06K
2024-07-12Milnes AlistairBuy17.60K$1.1420.06K
2024-07-12Uzialko Edward RBuy17.60K$1.1420.06K
2024-02-12Spector Richard D.Buy100.00K$1.10110.00K
2024-02-12Spector Richard D.Other0——
2024-02-01Currie Daniel ScottBuy61.90K$0.8049.52K
2024-02-01Elefant DovBuy84.00K$0.8067.20K
2024-02-01Thomas Christine EBuy32.60K$0.8026.08K
2024-02-01Lee-Sepsick KathyBuy204.90K$0.80163.92K
2023-11-21PharmaCyte Biotech, Inc.Sell4.24M$1.185.00M
2023-11-21PharmaCyte Biotech, Inc.Sell4.24M$1.185.00M
2023-11-21PharmaCyte Biotech, Inc.Sell4.24M$1.486.25M
2023-11-21Silverman JoshuaBuy17.00K$0.9015.30K
2023-11-21Silverman JoshuaOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 2, holders -34 vs prior quarter. Ownership 0.05%.

HolderSharesChangeChange %Value
CX INSTITUTIONAL750-14.25K-95.00%3.00K
IFP ADVISORS, INC1.00K00.00%306
CITIGROUP INC0-1.65K-100.00%0
VANGUARD FIDUCIARY TRUST CO0-249.88K-100.00%0
TRUST CO OF TOLEDO NA /OH/0-1.76K-100.00%0
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO0-20.00K-100.00%0
GEODE CAPITAL MANAGEMENT, LLC0-621.37K-100.00%0
WHITTIER TRUST CO OF NEVADA INC0-15.88K-100.00%0
MARINER, LLC0-18.74K-100.00%0
TWO SIGMA SECURITIES, LLC0-14.87K-100.00%0
HRT FINANCIAL LP0-26.74K-100.00%0
VIRTU FINANCIAL LLC0-80.15K-100.00%0
EP WEALTH ADVISORS, LLC0-100.00K-100.00%0
ALLWORTH FINANCIAL LP0-2.55K-100.00%0
JANE STREET GROUP, LLC0-32.28K-100.00%0
BROOKSTONE CAPITAL MANAGEMENT0-12.35K-100.00%0
UBS GROUP AG0-61.93K-100.00%0
WEALTHSPIRE ADVISORS, LLC0-28.13K-100.00%0
KESTRA PRIVATE WEALTH SERVICES, LLC0-15.00K-100.00%0
CETERA INVESTMENT ADVISERS0-62.00K-100.00%0
OSAIC HOLDINGS, INC.0-47.96K-100.00%0
KOVACK ADVISORS, INC.0-70.00K-100.00%0
ALJIAN CAPITAL MANAGEMENT, LLC0-25.27K-100.00%0
CLEAR CREEK FINANCIAL MANAGEMENT, LLC0-115.56K-100.00%0
BAY RIVERS GROUP0-19.00K-100.00%0

Earnings and financials

Femasys Inc. (FEMY) trades at $1.39, with a market cap of $11.64M and a trailing P/E of -0.33. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
929064103791811796891206218107197016291082293313

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Femasys (FEMY) Financials: Revenue & Earnings

FEMY$1.39+0.02 +1.46%

$11.64M

Market Cap

-0.33

P/E

0.61

Forward P/E

61

Score

Price History